Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
01/1999
01/07/1999EP0889129A2 GidA1 polypeptides from Staphylococcus aureus
01/07/1999EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase
01/07/1999EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases
01/07/1999DE19829229A1 Hydrazinderivate Hydrazine
01/07/1999CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
01/07/1999CA2295089A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases
01/05/1999US5856129 Hydridized detector
01/03/1999CA2236462A1 Murc
01/01/1999CA2236452A1 Gida1
12/1998
12/30/1998WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues
12/30/1998WO1998040404A3 Secreted proteins and polynucleotides encoding them
12/30/1998EP0887416A2 Human AFC1
12/30/1998CN1041420C Process for preparing N-acyl-2,3-benzodiazepine derivatives
12/24/1998CA2234418A1 Human afc1
12/23/1998EP0885309A1 Direct molecular diagnosis of friedreich ataxia
12/23/1998CN1202826A Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral scherosis
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5852003 Drug and pharmaceutical composition for the treatment of muscles
12/17/1998WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2293363A1 Secreted proteins and polynucleotides encoding them
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998CN1201390A 5-HT3 receptor antagonists for treating dyskinesia
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998US5846935 Modified ciliary neurotrophic factors
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054189A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998WO1998054184A1 1,6-naphthyridine anti-convulsants
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054152A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2291254A1 1,6-naphthyridine anti-convulsants
12/03/1998CA2289578A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998CA2289576A1 Azacyclooctane and heptane derivatives, their preparation and use in therapy
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998CN1200728A Novel 2-ar(alk)yl-imidazolin-2-ones contg. a disubstituted amine radical in the 4th position having an anti-convulsive effect, and prodn. method therefor
12/02/1998CN1200670A Pharmaceutical compositions contg. hydroximic acid derivatives
12/02/1998CN1200288A Tung oil plaster for reinforcing muscles and strengthening bones
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
11/1998
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/25/1998EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects
11/24/1998US5840906 Forming anabaseine using nicotinyl piperidone salt
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/17/1998US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/10/1998US5834457 Administering a copper chelating agent to inhibit free radical production of mutant superoxidase dismutase; familial amyotrophic lateral sclerosis
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049134A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate
11/05/1998WO1998048802A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0874851A2 Macrocyclic compounds made from suboxide units
11/04/1998EP0874621A1 Pharmaceutical compositions
11/03/1998US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
11/03/1998US5830870 Prevent loss of muscle mass
10/1998
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998047906A1 Phosphonic acid derivatives
10/29/1998WO1998047506A1 Gastric-retained pharmaceutical composition
10/29/1998CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2286081A1 Gastric-retained pharmaceutical composition
10/22/1998WO1998002190A3 Cationic amphiphile/dna complexes
10/21/1998EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871420A1 Triacetin as a transdermal penetration enhancer
10/15/1998WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998WO1998045327A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
10/15/1998WO1998045322A2 Diagnosis method and reagents
10/15/1998WO1998045256A1 Hydroxamic acid derivatives
10/15/1998WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998CA2287084A1 Diagnosis method and reagents
10/15/1998CA2285906A1 Hydroxamic acid derivatives
10/15/1998CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/14/1998EP0870761A1 Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
10/13/1998US5821123 Modified antibody variable domains
10/08/1998WO1998043956A1 1,4-substituted cyclic amine derivatives
10/08/1998WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/07/1998EP0868511A1 Utrophin gene expression
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/06/1998US5817494 Anticancer agents; viricides
10/01/1998WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998WO1998042738A1 87 human secreted proteins
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 233